Vaccitech (VACC) Stock Analysis

What Vaccitech does

Vaccitech plc is a clinical-stage biopharmaceutical company focused on developing cutting-edge T-cell immunotherapeutics and vaccines. Their mission is to treat and prevent a variety of infectious diseases and cancers. The company's therapeutic pipeline includes several programs undergoing clinical evaluation: VTP-300 is in Phase 1/2a clinical trials for chronic hepatitis B. VTP-200 is also in Phase 1/2a development, targeting human papillomavirus (HPV) infection. VTP-850 is progressing through Phase 1/2 clinical studies for prostate cancer. VTP-600 is engaged in Phase 1/2a trials for non-small cell lung cancer. In terms of prevention, their prophylactic initiatives feature: VTP-400, which is in a preclinical stage, designed to combat herpes zoster (shingles). VTP-500, which has concluded Phase 1 clinical trials for Middle East respiratory syndrome (MERS). Notably, Vaxzevria, a preventive vaccine against COVID-19 infection, is also part of their offerings. Established in 2016, the company was originally named Vaccitech Rx Limited before adopting its current name, Vaccitech plc, in March 2021. Vaccitech plc is headquartered in Oxford, United Kingdom.

Key metrics

ETFs linked to VACC

Broad-market and Healthcare sector ETFs an investor holding Vaccitech is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how VACC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Vaccitech?

Vaccitech trades under the ticker VACC on NASDAQ.

Which exchange is VACC listed on?

VACC is listed on NASDAQ.

What sector does Vaccitech operate in?

Vaccitech is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze VACC in a portfolio?

PortView shows VACC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.